Rating
Buy
Price target
$425
Previous
$435
Implied upside
+41%

UBS analyst Timothy Arcuri lowered the price target on Lam Research (NASDAQ: LRCX) to $425 (from $435) while maintaining a Buy rating on September 1, 2026.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Previous notes from UBS on Lam Research

UBS Buy ReiterateJul 15, 2026 from $375 UBS Buy Raises targetJun 9, 2026 $375from $310 UBS Buy ReiterateApr 23, 2026 $310maintained

Other Lam Research notes

MizuhoBuy Lowers target · Aug 25, 2026 $365from $370 BernsteinBuy Reiterate · Aug 10, 2026 from $360 B RileyBuy Reiterate · Jul 30, 2026 from $385 Wells FargoBuy Reiterate · Jul 30, 2026 from $450 Morgan StanleyBuy Reiterate · Jul 30, 2026 from $404

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.